This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Katholieke Universiteit Leuven, Korea Research Institute of Chemical Technology, Novartis Ag. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 631 
2 out of 655 
2 out of 3,978 
Years Active: 2024-2025
Title: Yashwardhan R Malpani: Innovator in Antiviral Compounds
Introduction
Yashwardhan R Malpani is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of antiviral research, holding two patents that showcase his innovative spirit and dedication to advancing medical science.
Latest Patents
Malpani's latest patents include the development of antiviral 1,3-di-oxo-indene compounds. These compounds are described in his patent as having the potential to provide therapeutic benefits against viral infections. The invention provides compounds of Formula (I), which are crucial in the ongoing fight against viral diseases.
Career Highlights
Throughout his career, Yashwardhan R Malpani has worked with prominent organizations such as Novartis AG and Katholieke Universiteit Leuven. His experience in these esteemed institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Malpani has collaborated with notable researchers, including Johan Neyts and Daniel J Poon. These partnerships have further enriched his work and expanded the impact of his inventions in the scientific community.
Conclusion
Yashwardhan R Malpani is a distinguished inventor whose work in antiviral compounds has the potential to make a significant impact on public health. His contributions to the field reflect his commitment to innovation and excellence in research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile